Companies / Doctomatic
Doctomatic
United States
Doctomatic provides a regulatory-grade, AI-powered ingestion layer that converts any medical device reading into structured vitals
Doctomatic, based in United States, has 2 investors on file, among them Plus Partners and Ship2B Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Plus Partners
51 companies on its checked portfolioIts portfolio leans to Fintech (17%), Real Estate & Construction (12%), Enterprise Software (12%).
More from Ship2B Ventures
43 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (33%), Industrial & Manufacturing (12%), Education (10%).
See Ship2B Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Doctomatic and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Plus Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/doctomatic.com/investors
# also
GET /v1/companies/doctomatic.com
GET /v1/companies/doctomatic.com/news